DI MARIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 17.654
EU - Europa 11.822
AS - Asia 7.515
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 15
OC - Oceania 13
SA - Sud America 9
Totale 37.087
Nazione #
US - Stati Uniti d'America 17.386
CN - Cina 5.822
IE - Irlanda 4.177
SE - Svezia 3.246
TR - Turchia 1.414
UA - Ucraina 1.201
FI - Finlandia 1.010
DE - Germania 737
IT - Italia 581
CA - Canada 261
BE - Belgio 245
GB - Regno Unito 218
IN - India 110
AT - Austria 96
EU - Europa 59
FR - Francia 51
NL - Olanda 49
CZ - Repubblica Ceca 46
RO - Romania 45
SG - Singapore 44
IR - Iran 37
HU - Ungheria 22
JP - Giappone 19
KR - Corea 15
RU - Federazione Russa 14
PL - Polonia 12
AU - Australia 11
BG - Bulgaria 11
ES - Italia 11
HK - Hong Kong 11
SK - Slovacchia (Repubblica Slovacca) 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
IL - Israele 7
CH - Svizzera 6
CI - Costa d'Avorio 6
EG - Egitto 5
ID - Indonesia 5
RS - Serbia 5
VN - Vietnam 5
BR - Brasile 4
LU - Lussemburgo 4
CL - Cile 3
EE - Estonia 3
GR - Grecia 3
MD - Moldavia 3
PA - Panama 3
PT - Portogallo 3
BH - Bahrain 2
EC - Ecuador 2
LK - Sri Lanka 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CR - Costa Rica 1
DK - Danimarca 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PR - Porto Rico 1
SM - San Marino 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 37.087
Città #
Chandler 4.808
Dublin 4.171
Dearborn 1.619
Nanjing 1.309
Ashburn 1.281
Izmir 1.233
Jacksonville 1.222
Beijing 1.213
Princeton 831
Wilmington 464
San Mateo 446
New York 426
Ann Arbor 399
Shenyang 372
Nanchang 353
Helsinki 338
Hebei 297
Shanghai 240
Kunming 239
Brussels 235
Toronto 227
Jinan 216
Changsha 203
Jiaxing 198
Tianjin 198
Hefei 182
Kocaeli 174
Boardman 160
Parma 141
Norwalk 131
Seattle 108
Hangzhou 103
Fremont 92
Guangzhou 91
Pune 86
Vienna 83
Zhengzhou 79
Des Moines 72
Bremen 70
Ningbo 64
Woodbridge 48
Houston 45
Washington 43
Grafing 38
Taizhou 35
Edinburgh 34
Brno 32
Haikou 32
Lanzhou 32
Cambridge 28
Borås 27
Fuzhou 25
Shaoxing 25
Chengdu 24
Rockville 24
Taiyuan 24
Milan 23
Wuhan 23
Budapest 22
Leawood 22
Timisoara 20
Xian 20
Chongqing 19
Redmond 17
Andover 15
Bologna 15
Changchun 15
Los Angeles 15
Augusta 14
Chicago 14
Rio Saliceto 13
Stockholm 13
Philadelphia 12
Hanover 11
Redwood City 11
Sofia 11
Wenzhou 11
Baotou 10
Padova 10
Zanjan 10
Auburn Hills 9
Bucharest 9
Focsani 9
Frankfurt am Main 9
Bratislava 8
Dronten 8
Quzhou 8
Tappahannock 8
Warsaw 8
Chieti 7
Dubai 7
Florence 7
Huzhou 7
London 7
Madrid 7
Old Bridge 7
Rome 7
Tokyo 7
Turin 7
Atlanta 6
Totale 25.208
Nome #
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 117
Approach to gastroenterological diseases in primary care 95
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 95
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 86
Thyroid and celiac disease in pediatric age: a literature review 83
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 81
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 80
How and when investigating and treating Helicobacter pylori infection in children 80
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 79
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 79
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 77
Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H pylori infection? 77
Conservative treatment of acute appendicitis 76
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 75
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 74
Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study 73
Association of keratin 8 gene mutation with chronic pancreatitis 73
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 73
Autoimmune diseases in autoimmune atrophic gastritis 73
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 73
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 73
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 72
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 71
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 71
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 70
Efficacy of one-week triple therapies with low-dose rabeprazole and clarithromycin plus standard-dose amoxicillin or tinidazole for the cure of H pylori infection in elderly patients 69
Epidemiology and risk factors of pancreatic cancer 69
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 69
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 67
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 67
La Biopsie biochimica gastrica 67
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 67
Efficacy of a therapeutic strategy for eradication ofHelicobacter pyloriinfection 67
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 67
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 67
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 67
Efficacy of 5-ASA in the treatment of colonic diverticular disease 67
Effects of gastroesophageal reflux disease in laryngeal carcinoma 66
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 66
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 65
Treatment of Helicobacter pylori infection. 65
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 65
Does chronic hypercalcemia influence serum pepsinogens levels? 65
Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring helicobacter pylori infection: A randomized controlled trial 65
Sequential Therapy vs. Standard Triple Therapy Lasting 7 Days: Results of a Prospective Study 65
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 64
Low-doses versus standard-doses of clarithromicin in combination with amoxycillin and rabeprazole for the eradication of H. pylori infection in elderly subjects 64
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 64
OC.18.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM ADMINISTRATION: A 6 MONTHS STUDY IN ATROPHIC GASTRITIS SUBJECTS 64
Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a prospective four years study 64
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 64
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 64
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 64
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 64
Advanced gastric cancer: the value of surgery 64
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 64
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 64
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 64
Prevalence of gastrointestinal diseases in elderly population: epidemiological survey in north-east of Italy 63
COX1 plus PPI or COX2 in acute osteoarthritis for prevention of gastroduodenal damage ? A prospective four weeks study 63
Acid-related disorders in the elderly 63
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 63
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 63
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 63
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) 63
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 63
Topography of gastric damage in H.pylori infection: evaluation by serum pepsinogens levels 62
Pantoprazole in eradication of peptic ulcer H pylori (Hp) positive patients: a multicentre randomized prospective study by gisu (interdisciplinary ulcer study group) 62
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia 62
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 62
A new marker for monitoring alcohol abuse? A pilot study on heavy drinkers 62
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 62
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY 62
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 62
Lactoferrin: mechanism of action, clinical significance and therapeutic 61
Gastropanel as screening of gastric atrophy in primary care 61
Therapy of NERD: single Vs double rabeprazole dosage 61
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 61
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 61
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 61
Emorragia gastrointestinale 61
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 61
EFFECTIVENESS AND SAFETY OF PYLERA® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY 61
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 61
Helicobacter pylori non-cytotoxic genotipe enhances mucosal gastrin and MAST cell triptase 60
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study 60
Keratin 8 mutations in patients with chronic pancreatitis 60
Virulence H. pylori genes cagA and oipA interplay with IL1b and IL1-RN host genes in favoring preneoplastic and neoplastic gastric lesions 60
Prevalence of colorectalcarcinoma in a high risk area of north Italy 60
MONOCYTE CHEMOTACTIC PROTEIN -1 POLYMORPHISM IS ASSOCIATED WITH ACUTE RECURRENT PANCREATITIS 60
Hypercalcemia due to ectopic secretion of parathyriod related protein from pancreatic carcinoma: a case report 60
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 60
Reply 60
Chronic nicotine intake causes vascular dysregulation in the rat gastric mucosa 60
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 60
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 60
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 60
Efficacy of mesalazine in the treatment of symptomatic diverticular disease 59
Quadro clinico ed endoscopico 59
Comparison of omeprazole, pantoprazole and rabeprazole in the treatment of severe esophagitis in elderly patients 59
Totale 6.707
Categoria #
all - tutte 123.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.060 0 0 0 0 0 0 0 0 205 36 1.476 343
2019/20208.024 2.144 1.042 277 145 562 1.193 817 184 411 789 173 287
2020/20212.322 47 278 272 18 295 49 260 11 431 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202315.400 1.540 1.337 984 1.304 1.153 1.798 132 1.144 5.205 78 578 147
2023/20243.680 264 595 154 148 455 1.364 214 351 135 0 0 0
Totale 37.800